Exhaled markers of antioxidant activity and oxidative stress in stable cystic fibrosis patients with moderate lung disease
- 20 February 2018
- journal article
- research article
- Published by IOP Publishing in Journal of Breath Research
- Vol. 12 (2) , 026010
Abstract
The sustained imbalance between oxidant and antioxidant species contributes to lung damage in patients with cystic fibrosis (CF). Glutathione (GSH) is an important component of the antioxidant defense in the airways epithelial lining fluid and its transportation out of the cells may be altered in CF. The aim of this study was to assess the oxidants/antioxidants balance in the airways of patients with CF. We measured the concentrations of GSH, the total antioxidant capacity and the concentration of 8-iso-prostaglandin F 2 α (8-isoprostane), a marker of oxidative stress, in the exhaled breath condensate of 17 non-smoking patients with CF, in stable phase, and in 17 age-matched healthy subjects. The levels of GSH and total antioxidant capacity in patients with CF were significantly lower than in healthy subjects (0.66 ± 0.07 μ M versus 1.30 ± 0.08 μ M, p < 0.001, respectively for GSH; 0.157 ± 0.02 mM and 0.32 ± 0.01 mM, p < 0.05, respectively for antioxidant capacity). The concentration of 8-isoprostane was higher in CF than in healthy controls (26.5 ± 0.1 pg ml −1 versus 10.8 ± 0.1 pg ml −1 ; p < 0.05). A low concentration of antioxidant agents, particularly glutathione, and increased levels of 8-isoprostane in the exhaled breath suggest an altered oxidizing environment in the airways of patients with CF. This altered redox environment in the epithelial liquid surface may contribute to progressive lung disease.Keywords
This publication has 28 references indexed in Scilit:
- Redox balance in Cystic FibrosisThe International Journal of Biochemistry & Cell Biology, 2014
- Myeloperoxidase and Protein Oxidation in the Airways of Young Children with Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Antioxidant deficiency in cystic fibrosis: when is the right time to take action?The American Journal of Clinical Nutrition, 2004
- Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbationPediatric Pulmonology, 2004
- Aldehydes and Glutathione in Exhaled Breath Condensate of Children with Asthma ExacerbationAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Analysis of Expired Air for Oxidation ProductsAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosisThorax, 2000
- Evidence for Increased oxidative Damage in Patients with Cystic FibrosisPediatric Research, 1994
- Systemic deficiency of glutathione in cystic fibrosisJournal of Applied Physiology, 1993
- Normal alveolar epithelial lining fluid contains high levels of glutathioneJournal of Applied Physiology, 1987